Kurs
-0,25%
Likviditet
51,7 MDKK
Kalender
| Tid* | ||
| 2025-08-12 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-03-06 | N/A | Årsstämma |
| 2025-02-05 | 07:30 | Bokslutskommuniké 2024 |
| 2024-08-14 | - | Kvartalsrapport 2024-Q2 |
| 2024-03-07 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2024-03-06 | - | Årsstämma |
| 2024-02-06 | - | Bokslutskommuniké 2023 |
| 2023-08-15 | - | Kvartalsrapport 2023-Q2 |
| 2023-03-09 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2023-03-08 | - | Årsstämma |
| 2023-02-07 | - | Bokslutskommuniké 2022 |
| 2022-08-16 | - | Kvartalsrapport 2022-Q2 |
| 2022-03-11 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2022-03-10 | - | Årsstämma |
| 2022-02-08 | - | Bokslutskommuniké 2021 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-03-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2021-03-05 | - | Årsstämma |
| 2021-02-09 | - | Bokslutskommuniké 2020 |
| 2020-08-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-03-11 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2020-03-10 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-08-14 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-20 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2019-03-19 | - | Årsstämma |
| 2019-02-19 | - | Bokslutskommuniké 2018 |
| 2018-08-15 | - | Kvartalsrapport 2018-Q2 |
| 2018-03-23 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2018-03-22 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-08-14 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-28 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2017-03-27 | - | Årsstämma |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-10 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-25 | - | Split DEMANT 1:5 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2016-04-07 | - | Årsstämma |
| 2016-03-01 | - | Bokslutskommuniké 2015 |
| 2015-11-12 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2015-04-09 | - | Årsstämma |
| 2015-02-26 | - | Bokslutskommuniké 2014 |
| 2014-11-13 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-14 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2014-04-09 | - | Årsstämma |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-11-05 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-14 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2013-04-09 | - | Årsstämma |
| 2013-02-26 | - | Bokslutskommuniké 2012 |
| 2012-11-07 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-12 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2012-04-11 | - | Årsstämma |
| 2012-02-29 | - | Bokslutskommuniké 2011 |
| 2011-11-10 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-19 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2011-04-13 | - | Årsstämma |
| 2010-11-16 | - | Kvartalsrapport 2010-Q3 |
| 2010-04-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
21.11.2023 07:30:14 CET | Demant A/S | Inside information
Company announcement no 2023-14 21 November 2023
Demant to resume share buy-backs
It has previously been announced that the Group may resume its share buy-backs in 2023. In line with this, Demant announces today that it has decided to resume its share buy-backs following material deleveraging during 2023 thanks to strong cash flow generation throughout the year. Also, the level of acquisitions has been lower than originally planned, as some acquisitions are now expected to close in 2024.
There are no changes to the Group’s outlook for 2023, and the gearing multiple (NIBD/EBITDA) at the end of 2023 is still expected to be within the medium- to long-term target of 2.0-2.5.
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Henrik Axel Lynge Buchter, Manager of External Communication |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.